Major bleeding with old and novel oral anticoagulants: How tomanage it. Focus on general measures

被引：7

作者：

Di Fusco, Stefania Angela ^{[1
,9
]}

Luca, Fabiana ^{[2
,9
]}

Benvenuto, Manuela ^{[3
,9
]}

Iorio, Annamaria ^{[4
]}

Fiscella, Damiana ^{[5
,9
]}

D'Ascenzo, Fabrizio ^{[6
,9
]}

Madeo, Andrea ^{[7
,9
]}

Colivicchi, Furio ^{[1
]}

Di Lenarda, Andrea ^{[8
,10
]}

Gulizia, Michele Massimo ^{[5
,9
]}

机构：

[1] San Filippo Neri Hosp, Cardiol Unit, Via Martinotti 20, I-00135 Rome, Italy

[2] Big Metropolitan Hosp Melacrino Morelli, Cardiol Dept, Reggio Di Calabria, Italy

[3] Augusto Murri Hosp, Cardiol Unit, Fermo, Italy

[4] Papa Giovanni XXIII Hosp, Cardiol Dept, Bergamo, Italy

[5] Azienda Rilevo Nazl & Alta Specialita, Osped Garibaldi Nesima, Cardiol Dept, Catania, Italy

[6] Univ Turin, Citta Salute & Sci, Dept Internal Med, Div Cardiol, Turin, Italy

[7] San Camillo Forlanini Hosp, Cardiol Dept, Rome, Italy

[8] Trieste Hosp, Cardiovasc Ctr, Trieste, Italy

[9] Area Giovani ANMCO, Florence, Italy

[10] ANMCO Board, Florence, Italy

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2018年 / 268卷

关键词：

Major bleeding; Non-vitamin K antagonist oral anticoagulants; Vitamin-K antagonists; Warfarin; HEART RHYTHM ASSOCIATION; ATRIAL-FIBRILLATION; DABIGATRAN ETEXILATE; PRACTICAL GUIDE; WARFARIN; MANAGEMENT; APIXABAN; EDOXABAN; SAFETY; RISK;

D O I：

10.1016/j.ijcard.2018.05.061

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

has changed the therapeutic landscape in the prevention of thromboembolic events. Although NOACs compared to vitamin K antagonists (VKAs) have demonstrated a similar or slightly lower rate of major bleeding and a lower rate of intracranial or fatal bleeding, hemorrhaging still represents the main adverse effect of anticoagulant treatment. This review reports data on the rates of major bleeding with old and new oral anticoagulants. It analyses laboratory tests that can be used to assess the intensity of anticoagulation in patients treated with oral anticoagulants and discusses general measures to implement in managing major bleeding. (C) 2018 Elsevier B.V. All rights reserved.

引用

页码：80 / 84

页数：5

共 35 条

[11] Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation [J].

Heidbuchel, Hein ;

Verhamme, Peter ;

Alings, Marco ;

Antz, Matthias ;

Diener, Hans-Christoph ;

Hacke, Werner ;

Oldgren, Jonas ;

Sinnaeve, Peter ;

Camm, A. John ;

Kirchhof, Paulus .

EUROPACE, 2015, 17 (10) :1467-1507

[12] Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].

Hemphill, J. Claude, III ;

Greenberg, Steven M. ;

Anderson, Craig S. ;

Becker, Kyra ;

Bendok, Bernard R. ;

Cushman, Mary ;

Fung, Gordon L. ;

Goldstein, Joshua N. ;

Macdonald, R. Loch ;

Mitchell, Pamela H. ;

Scott, Phillip A. ;

Selim, Magdy H. ;

Woo, Daniel .

STROKE, 2015, 46 (07) :2032-2060

[13] The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study [J].

Hijazi, Ziad ;

Oldgren, Jonas ;

Lindback, Johan ;

Alexander, John H. ;

Connolly, Stuart J. ;

Eikelboom, John W. ;

Ezekowitz, Michael D. ;

Held, Claes ;

Hylek, Elaine M. ;

Lopes, Renato D. ;

Siegbahn, Agneta ;

Yusuf, Salim ;

Granger, Christopher B. ;

Wallentin, Lars .

LANCET, 2016, 387 (10035) :2302-2311

[14] New oral anticoagulants: a practical guide for physicians [J].

Hinojar, Rocio ;

Julio Jimenez-Natcher, Jose ;

Fernandez-Golfin, Covadonga ;

Luis Zamorano, Jose .

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (02) :134-145

[15]

Jun M., 2017, BMJ-BRIT MED J, P359

[16] Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials [J].

Kakkos, S. K. ;

Kirkilesis, G. I. ;

Tsolakis, I. A. .

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (05) :565-575

[17] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [J].

Kirchhof, Paulus ;

Benussi, Stefano ;

Kotecha, Dipak ;

Ahlsson, Anders ;

Atar, Dan ;

Casadei, Barbara ;

Castella, Manuel ;

Diener, Hans-Christoph ;

Heidbuchel, Hein ;

Hendriks, Jeroen ;

Hindricks, Gerhard ;

Manolis, Antonis S. ;

Oldgren, Jonas ;

Popescu, Bogdan Alexandru ;

Schotten, Ulrich ;

Van Putte, Bart ;

Vardas, Panagiotis .

EUROPEAN HEART JOURNAL, 2016, 37 (38) :2893-+

[18] Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 [J].

Krijthe, Bouwe P. ;

Kunst, Anton ;

Benjamin, Emelia J. ;

Lip, Gregory Y. H. ;

Franco, Oscar H. ;

Hofman, Albert ;

Witteman, Jacqueline C. M. ;

Stricker, Bruno H. ;

Heeringa, Jan .

EUROPEAN HEART JOURNAL, 2013, 34 (35) :2746-2751

[19] Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients [J].

Laliberte, Francois ;

Cloutier, Michel ;

Nelson, Winnie W. ;

Coleman, Craig I. ;

Pilon, Dominic ;

Olson, William H. ;

Damaraju, C. V. ;

Schein, Jeffrey R. ;

Lefebvre, Patrick .

CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) :1317-1325

[20] Efficacy and Safety of Dabigatran Etexilate and Warfarin in "Real-World" Patients With Atrial Fibrillation A Prospective Nationwide Cohort Study [J].

Larsen, Torben Bjerregaard ;

Rasmussen, Lars Hvilsted ;

Skjoth, Flemming ;

Due, Karen Margrete ;

Callreus, Torbjorn ;

Rosenzweig, Mary ;

Lip, Gregory Y. H. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (22) :2264-2273

← 1 2 3 4 →